Evidence map›Paper›PMID 31888771›Full record

ArticleActa neuropathologica communications2019

α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.

Nolwen L Rey, Luc Bousset, Sonia George, Zachary Madaj, Lindsay Meyerdirk, Emily Schulz, Jennifer A Steiner, Ronald Melki, Patrik Brundin

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 114 citations in OpenAlex.

  1. From aggregate structure to disease trajectory: the role of the proteostasis network.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Brain communications · 2025
    Article
  9. Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.Movement disorders : official journal of the Movement Disorder Society · 2024
    Review
  10. Article
  11. LRRK2-Associated Parkinsonism With and WithoutmedRxiv : the preprint server for health sciences · 2024
    Article
  12. Review
  13. Article
  14. Alpha-synuclein aggregates are phosphatase resistant.Acta neuropathologica communications · 2024
    Article
  15. Article
  16. Article
  17. Alpha-synuclein aggregates are phosphatase resistant.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Review
  20. Liquid-liquid phase separation and conformational strains ofFrontiers in molecular neuroscience · 2024
    Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nolwen L ReyCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA. Nolwen.Rey@cnrs.fr.ORCID 0000-0003-1381-3492
Luc BoussetInstitut François Jacob (MIRCen), CEA and Laboratory of Neurodegenerative diseases, UMR 9199 CNRS, 18 route du Panorama, 92265, Fontenay-aux-Roses, France.
Sonia GeorgeCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Zachary MadajBioinformatics and Biostatistics Core, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Lindsay MeyerdirkCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Emily SchulzCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Jennifer A SteinerCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Ronald MelkiInstitut François Jacob (MIRCen), CEA and Laboratory of Neurodegenerative diseases, UMR 9199 CNRS, 18 route du Panorama, 92265, Fontenay-aux-Roses, France.
Patrik BrundinCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue N.E, Grand Rapids, MI, 49503, USA.
Van Andel Institute · USCentre National de la Recherche Scientifique · FR

Funding

Linking Synucleinopathy and Dysfunction of Olfactory PathwaysR01DC016519 · NIDCD · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN, WESSON, DANIEL W · 2017 to 2021
$2.8M
Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons diseaseR21NS106078 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI BRUNDIN, PATRIK, KORDOWER, JEFFREY H · 2019 to 2020
$921k
Does Microglial Activation Influence Propagation of Alpha-synuclein PathologyR21NS093993 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI BRUNDIN, PATRIK · 2016 to 2017
$523k
NIDCD NIH HHS R01 DC016519NIH HHS 1R01DC016519-01NIH HHS 1R21NS106078-01A1NIH HHS 5R21NS093993-02NINDS NIH HHS R21 NS093993NINDS NIH HHS R21 NS106078
6 · The paper itself

Abstract

Alpha-synuclein inclusions, the hallmarks of synucleinopathies, are suggested to spread along neuronal connections in a stereotypical pattern in the brains of patients. Ample evidence now supports that pathological forms of alpha-synuclein propagate in cell culture models and in vivo in a prion-like manner. However, it is still not known why the same pathological protein targets different cell populations, propagates with different kinetics and leads to a variety of diseases (synucleinopathies) with distinct clinical features. The aggregation of the protein alpha-synuclein yields different conformational polymorphs called strains. These strains exhibit distinct biochemical, physical and structural features they are able to imprint to newly recruited alpha-synuclein. This had led to the view that the clinical heterogeneity observed in synucleinopathies might be due to distinct pathological alpha-synuclein strains.To investigate the pathological effects of alpha-synuclein strains in vivo, we injected five different pure strains we generated de novo (fibrils, ribbons, fibrils-65, fibrils-91, fibrils-110) into the olfactory bulb of wild-type female mice. We demonstrate that they seed and propagate pathology throughout the olfactory network within the brain to different extents. We show strain-dependent inclusions formation in neurites or cell bodies. We detect thioflavin S-positive inclusions indicating the presence of mature amyloid aggregates.In conclusion, alpha-synuclein strains seed the aggregation of their cellular counterparts to different extents and spread differentially within the central nervous system yielding distinct propagation patterns. We provide here the proof-of-concept that the conformation adopted by alpha-synuclein assemblies determines their ability to amplify and propagate in the brain in vivo. Our observations support the view that alpha-synuclein polymorphs may underlie different propagation patterns within human brains.

Indexed as

alpha-SynucleinAnimalsFemaleHumansInclusion BodiesMice, Inbred C57BLNeuronsOlfactory BulbSynucleinopathiesalpha-SynucleinAlpha-synucleinFibrilsOlfactory bulbPrion-like spreadingStrains

Identifiers

PMID31888771
PMCPMC6937797
OpenAlexW2997280667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.